Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
DRIO

DRIO - DarioHealth Corp Stock Price, Fair Value and News

$10.96-0.11 (-0.99%)
Market Closed

33/100

DRIO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

33/100

DRIO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$9.41

Target 3M

$11.03

Target 6M

$10.46

DRIO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DRIO Price Action

Last 7 days

-9.1%

Last 30 days

4.5%

Last 90 days

-19.8%

Trailing 12 Months

-20.6%

DRIO RSI Chart

DRIO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DRIO Valuation

Market Cap

74.2M

Price/Earnings (Trailing)

-1.75

Price/Sales (Trailing)

3

EV/EBITDA

-1.92

Price/Free Cashflow

-2.76

DRIO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$9.41

Target 3M

$11.03

Target 6M

$10.46

DRIO Fundamentals

DRIO Revenue

Revenue (TTM)

24.7M

Rev. Growth (Yr)

-32.55%

Rev. Growth (Qtr)

-6.74%

DRIO Earnings

Earnings (TTM)

-42.3M

Earnings Growth (Yr)

15.12%

Earnings Growth (Qtr)

19.43%

DRIO Profitability

Operating Margin

89.02%

EBT Margin

-170.38%

Return on Equity

-56.47%

Return on Assets

-35.94%

Free Cashflow Yield

-36.29%

DRIO Investor Care

Shares Dilution (1Y)

297.00%

Diluted EPS (TTM)

11.12

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202528.0M27.1M24.7M0
202419.0M19.1M23.1M27.0M
202326.7M26.6M23.5M20.4M
202225.0M25.9M26.9M27.7M
20219.5M13.0M16.6M20.5M
20207.0M7.1M7.3M7.6M
20197.9M7.5M7.5M7.6M
20185.9M6.8M7.3M7.4M
20173.2M3.8M4.4M5.2M
20161.3M1.8M2.3M2.8M
2015244.0K437.0K630.0K823.0K
201400051.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About DarioHealth Corp

DRIO
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its user-centric multi-chronic condition digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move to address most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
 CEO
 WEBSITEdariohealth.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES241

DarioHealth Corp Frequently Asked Questions

DRIO is the stock ticker symbol of DarioHealth Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of DarioHealth Corp is 74.18 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check DRIO's fair value in chart for subscribers.

The fair value guage provides a quick view whether DRIO is over valued or under valued. Whether DarioHealth Corp is cheap or expensive depends on the assumptions which impact DarioHealth Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DRIO.

As of Wed Jan 28 2026, DRIO's PE ratio (Price to Earnings) is -1.75 and Price to Sales (PS) ratio is 3. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DRIO PE ratio will change depending on the future growth rate expectations of investors.